Novogen Patent Covering Cantrixil, Trilexium Accepted in Australia
November 12, 2015 at 07:22 AM EST
Novogen Limited (NASDAQ: NVGN) today announced that a patent application covering two of its key lead superbenzopyran (SBP) drug ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.